Skip to main content
SNN
NYSE Industrial Applications And Services

Cevian Capital lifts Smith & Nephew stake to 14.18% with $125M in fresh purchases

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$31.12
Mkt Cap
$12.756B
52W Low
$28.555
52W High
$38.79
52W Position info
9.0% above low
Off High info
20% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

SNN is trading near its 52-week low of $28.555 (9.0% above the low).

Summary

Activist investor Cevian Capital increased its stake in Smith & Nephew to 14.18% with $125 million in new purchases, extending a months-long buying campaign that now totals $1.67 billion.


Key Events · Ownership and Investor Activity · SNN

  • Stake Increased to 14.18%

    Between June 25 and July 24, 2026, Cevian Capital acquired an additional 8,374,918 shares, lifting its total ownership to 119,179,419 shares, or 14.18% of Smith & Nephew's outstanding ordinary shares.

  • New Purchases Total ~$125 Million

    The recent purchases were made at prices ranging from $14.69 to $15.27 per share, totaling approximately $125 million and bringing Cevian's aggregate investment to $1.67 billion.

  • Activist Campaign Continues

    This is the eighth amendment to Cevian's 13D filing since July 2024, reflecting a sustained activist campaign that has seen the stake grow from around 11% in early May 2026 to 14.18% now.

  • Purchases at Significant Discount to Current Price

    The shares were acquired at prices between $14.69 and $15.27, well below today's $31.12 stock price, indicating substantial unrealized gains on the recent purchases.


Analysis · SNN · Industrial Applications And Services

Activist investor Cevian Capital continues its aggressive accumulation of Smith & Nephew shares, raising its stake to 14.18% from 13.09% through purchases totaling approximately $125 million since late June. This marks the eighth amendment to Cevian's 13D filing and extends a pattern of steady buying that has seen the stake grow from around 11% in early May. The buying occurred at prices between $14.69 and $15.27 per share, well below today's $31.12 stock price, reflecting the significant share price appreciation since the purchases were made. Cevian's total investment now stands at approximately $1.67 billion, underscoring its conviction in the company's turnaround potential. The continued accumulation by a prominent activist investor signals strong confidence in Smith & Nephew's strategic direction and may pressure management to accelerate value-enhancing initiatives.

At the time of this filing, SNN was trading at $31.12 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $12.8B. The 52-week trading range was $28.56 to $38.79. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SNN - Latest Insights

SNN
Jul 09, 2026, 2:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $29.95
Real-time Price: $31.12 info
Change: +$1.17 (+4%) info
Market Cap: $12.756B info
SNN
Jun 30, 2026, 6:23 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $30.45
Real-time Price: $31.12 info
Change: +$0.670 (+2%) info
Market Cap: $12.756B info
SNN
Jun 26, 2026, 6:15 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $30.27
Real-time Price: $31.12 info
Change: +$0.850 (+3%) info
Market Cap: $12.756B info
SNN
Jun 24, 2026, 1:00 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $30.43
Real-time Price: $31.12 info
Change: +$0.695 (+2%) info
Market Cap: $12.756B info
SNN
Jun 17, 2026, 6:38 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $30.50
Real-time Price: $31.12 info
Change: +$0.620 (+2%) info
Market Cap: $12.756B info